Hepatitis C: latest news

Hepatitis C resources

Hepatitis C features

Hepatitis C in your own words

Hepatitis C news from aidsmap

More news

Hepatitis C news selected from other sources

  • Gilead pills priced at $1,000 a day are found cost-effective

    Health insurers that have been reluctant to cover hepatitis C drugs with list prices of $1,000 a daily dose will face more pressure after a report concluding the medications are “cost-effective” given their benefits.

    14 July 2015 | Bloomberg
  • Leading Canadian researcher calls for inclusion of co-infected people in large HCV clinical trials

    Stephen Shafran from the University of Alberta performed a major review of clinical trials of many DAA-containing HCV therapies used for the treatment of HCV mono-infection as well as HIV-HCV co-infection. Cure rates of HCV are “remarkably similar” in HCV mono-infected and co-infected participants who were treated with the same regimen and who have the same strain (genotype) of HCV.

    07 July 2015 | CATIE
  • US: Hepatitis C Rising -- Especially Among Young People -- and May Be Underestimated

    While hepatitis C has traditionally been predominant among Baby Boomers, the new report shows that HCV incidence is rising fastest among young people. But a recently published related study suggests that formal surveillance methods may grossly underestimate the number of people newly infected with HCV.

    06 July 2015 | HIVandHepatitis.com
  • Public health surveillance system may underestimate cases of acute hepatitis C infection

    A new study suggests massive under reporting may occur within the system set up by the US Centers for Disease Control and Prevention to estimate the incidence of acute hepatitis C virus infection. A research team found that less than 1 percent of a group of acute HCV patients in Massachusetts had been reported to the CDC, largely because required data was either not available or did not meet CDC definitions for acute HCV infection.

    02 July 2015 | Eurekalert Inf Dis
  • NHS accused of delaying access to 'highly tolerable' hepatitis C drugs over cost concerns

    The NHS has been accused by leading health charities of attempting to “severely limit” the introduction of new drugs to treat hepatitis C because they are too expensive – despite the cost of them being cleared by officials.

    17 June 2015 | The Independent
  • NHS England stumps up £190m for hep C therapy

    NHS England has agreed to invest a whopping £190 million this year in new treatments for hepatitis C, so that patients with liver cirrhosis can finally get NHS access to AbbVie’s new interferon-free antiviral regimen as well as Gilead’s Sovaldi and Harvoni, and thus hope for a cure.

    12 June 2015 | Pharma Times
  • Hep C… and Me?

    A hookup mentioned hepatitis C. It made me question my life. Should I be getting tested for hep C? Did I need to be asking tricks about their status? Was my blissful ignorance about hep C a problem?

    29 May 2015 | BETA blog
  • Philip Christopher Baldwin talks about living with hep C in the gay community

    I did not have the courage to tell people that I had Hep C, worried that others would gossip about me. There were no role models in the media for co-infection with HIV and Hep C, which made it harder to be open. I had fought so hard to be an out gay man, and now I was hiding something that was inextricably linked to my sexuality, to my identity and to my core sense of who I am.

    13 May 2015 | QX
  • Hepatitis C common among HIV-positive patients in sub-Saharan Africa

    Around 3% of people in sub-Saharan Africa have been infected with HCV infection, rising to 5.7 per cent in individuals with HIV. The findings will inform the global debate about how treatment should be made available to all those who need it.

    06 May 2015 | Eurekalert Inf Dis
  • Civil Society Groups Tell UNITAID: Support access mechanisms led by civil society, not the pharmaceutical industry

    Letters from global groups express deep concerns about the Medicines Patent Pool’s entry into hepatitis C treatment.

    05 May 2015 | Hep C Coalition
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.